A simple, direct solid-phase enzyme-labelled immunoassay for plasma cortisol was established using horseradish peroxidase/cortisol 21-hemisuccinate conjugate as 'enzyme label'. The antiserum, raised against a cortisol 21-hemisuccinate/bovine serum albumin conjugate, was coupled to cellulose to facilitate separation of free and bound steroid. Solvent extraction was avoided by the use of heat denaturation of the cortisol-binding globulin. This assay had a lower limit of sensitivity of 16·6 nrnol/l and satisfied the standard criteria of accuracy and precision.
SUMMARY A simple, direct solid-phase enzyme-labelled immunoassay for plasma cortisol was established using horseradish peroxidase/cortisol 21-hemisuccinate conjugate as 'enzyme label'. The antiserum, raised against a cortisol 21-hemisuccinate/bovine serum albumin conjugate, was coupled to cellulose to facilitate separation of free and bound steroid. Solvent extraction was avoided by the use of heat denaturation of the cortisol-binding globulin. This assay had a lower limit of sensitivity of 16·6 nrnol/l and satisfied the standard criteria of accuracy and precision.
Cortisol concentrations determined by enzymeimmunoassay were in excellent agreement with a gas liquid chromatography/mass spectrometry procedure (r=0'98, n= 19) and also with the radioimmunoassay in current use (r=0'95, n=20). Cortisol levels after ACTH stimulation and dexamethasone suppression in various subjects are presented. This enzymeimmunoassay is particularly applicable to the routine determination of plasma cortisol in small clinical laboratories or in those with a fluctuating workload.
The clinical value of plasma cortisol assays for investigating adrenocortical function is well established both as an initial screening test and in conjunction with a variety of suppression and stimulation tests (James and Landon, 1968 ). Since such investigations generate large numbers of samples an assay combining precision and specificity with low running costs, high sample throughput, and potential for automation would be valuable. Such an assay has been described (Seth and Brown, 1978; Riad-Fahmy et al., 1979) using a 125I-labelled radioligand and antiserum coupled to solid phase. Although this procedure was simple to perform and gave excellent results, even in the hands of inexperienced technicians, it required the radioligand to be resynthesised every four to six weeks, a point of importance, since concern has been expressed about the possible radiation hazard associated with the preparation and use of the 125I-radioligand.
The general principles of enzyme irnmunoassays have been well reviewed elsewhere (Scharpe et al., 1976; Schuurs and Van Weemen, 1977) , but the important features are the lack of any possible radiation hazard and the stability of the label. A further advantage is that the equipment required to determine the endpoint may be extremely cheap and simple. 53 The enzymeimmunoassay (EIA) for cortisol reported by Ogihara et al. (1977) has certain shortcomings, the most obvious being the use of the time-consuming second-antibody separation technique. The second antibody, and also the normal rabbit serum usually added to bulk up the precipitate, usually contains appreciable amounts of cortisol-binding globulins. These, by competing with the first antibody for cortisol, will contribute to the miscIassification error. Similar conclusions apply to the assay reported by Kobayashi et al. (1978) .
The procedure, reported by Comoglio and Celada (1976) , using a~-galactosidase label, is sensitive but critically dependent on the quality of the enzyme. Commercially available B-galactosidase is of low activity, and the facilities for Escherichia coli culture and extraction are not available to many immunoassay laboratories. In contrast, horseradish peroxidase (HRP) is commercially available in a quality suitable for EIA, and the enzyme was recommended as the best presently available at a recent meeting ('Enzyme-Linked Immuno-specific Assay for Infectious Agents', National Institute of Health, Bethesda, Md., USA, September 1979 ).
An EIA for cortisol has been established, using a cortisol-HRP label and a cellulose-coupled first anti-body raised to a cortisol 21-hemisuccinate-BSA conjugate, and has been shown to fulfil the usual criteria for a clinical assay.
Material and methods
All common solvents and reagents (Analar grade) were purchased from BDH Chemical Co Ltd, Poole, Dorset, UK, with the exception of ethanol, which was obtained from James Burroughs Ltd, London, UK. Cortisol, cortisol Zl-hemisuccinate, l l-deoxycortisol, deoxycorticosterone (DOC), 17-hydroxyprogesterone, progesterone, corticosterone, cortisone, dexamethasone, prednisolone, bovine serum albumin (Cohn Fraction V), and horseradish peroxidase (E.e.1.11.1.7, Reinheits-Zahl 3-42, the ratio of absorbances at 280 and 403 nm) and Brij 35 solution 30%, were all obtained from Sigma Chemical Co Ltd, UK. [2, 4, 6, 7, Cortisol (specific activity 82 Ci/mmol) was purchased from the Radiochemical centre, Amersham, Bucks, UK. Toluene, Triton X-IOO, scintillation grade, and 2,5-diphenyloxazole (PPO) were all obtained from Koch-Light Laboratories Ltd, CoIn brook, Bucks, UK. Sephadex G-25 was purchased from Pharrnacia Ltd, London, UK. Disposable polyethylene liquid scintillation counting vials were purchased from Griffiths & Neilsen Plastics Ltd, Billingshurst, Sussex, UK. Cyanogen bromide and a-phenylenediamine were purchased from Aldrich Chemical Co Ltd, Gillingham, Dorset, UK. Cellulose (microcrystalline) and benzene spectroscopic grade (Uvasol) were obtained from E. Merck, AG, Darmstadt, West Germany. Standard glass bacteriological test tubes (75 x 12 mrn), available from any general supplier, were used as received.
PLASMA SAMPLES Blood, collected by venepuncture, was placed in lithium heparin tubes and centrifuged, and the plasma was transferred to glass tubes and stored at -20°until required.
'CORTISOL-FREE' PLASMA This was obtained from normal healthy volunteers after adrenal suppression by a standard dose of dexamethasone (0'5 mg at 6-hour intervals for 24 hours).
CORTISOL SOLUTIONS
A stock standard solution (1 mg cortisol/IO ml ethanol) was stored at 4°e.
An intermediate stock cortisol solution was prepared by diluting the stock standard (100 ).11) to 10 ml Hindawi, Gaskell, Read and Riad-Fuhmy with cortisol-free plasma. Further dilution with cortisol-free plasma provided the working standards used to prepare the standard curve (0'5,1,2'5,5, 10, 15, and 20 ng in the final assay tube). Working standards, in 150 ).11 portions, were stored at -20°e. These standard solutions were stable for at least six months.
ASSAY AND SUBSTRATE BUFFER

Assay buffer
The assay buffer used in the EIA procedure was 0'01 M phosphate-buffered saline, pH 7-4, containing 0·1~~w/v bovine serum albumin.
Substrate buffer 0·2 M Anhydrous disodium hydrogen phosphate (14'2 g) was dissolved in distilled water (500 ml), and the pH was adjusted to 6·0 by addition of concentrated HCI.
Washing buffer
Substrate buffer containing 0·06~~Brij 35 detergent.
ANTISERUM TO CORTISOL
The antiserum used in this study, raised in rabbits against a cortisol-Zl-hemisuccinate-bovine serum albumin conjugate, was donated by Dr Butt, of the Birmingham and Midland Hospital for Women (Endocrine Department).
SOLlD-PHASE ANTISERUM
Cyanogen bromide activated cellulose, prepared by the method of Wide (1969) , was covalently coupled to BSA-adsorbed antiserum (Thorneycroft et al., 1970) using the procedure of Seth and Brown (1978) . The coupled antiserum suitably diluted (100-fold) in assay buffer was stable for at least six months when stored at 4°e.
PREPARATION OF 'ENZYME LABEL'
The enzyme label was prepared by coupling cortisol-21-hemisuccinate to horseradish peroxidase by a modified mixed anhydride procedure (Dawson et al., 1978) and purified by gel exclusion chromatography on Sephadex G-25. The molar incorporation ratio (number of moles of steroid per mole of enzyme) was determined by ultraviolet spectrometry as 1·7 mole/ mole.
The activity was determined by incubation of the substrate, a-phenylenediamine (2'8 mmoles) and hydrogen peroxide (0,006 %) in 0·2 M phosphate buffer for 1 hour in the dark at room temperature. Reaction was terminated by addition of 2 M sulphuric acid (0'6 rnl), and optical density of the supernate was then measured at 492 nm in a Gilford 300 N rapid sampling spectrophotometer.
Heat 60~30' TITRATION OF ENZYME LABEL Different concentrations of enzyme label (SO, 100, 200, 400, 500 ng/IOO Ill) were incubated overnight with solid-phase antiserum (100 Ill) in the presence and absence of varying concentrations (I, SO, lOOng/ tube) of added cortisol. After incubation the tubes were centrifuged (1300 g), and the pellet obtained was washed, twice with buffer containing detergent, and finally with substrate buffer. The enzyme activity in the pellet was assessed by the standard procedure.
ENZYME IMMUNOASSAY PROCEDURE
The enzyme immunoassay procedure finally adopted is illustrated (Fig. I) (100 Ill) were diluted with phosphate-saline buffer (400 Ill) and then heated for 30 minutes in a water-bath at 60°C. After cooling the tubes to room temperature, duplicate aliquots (100 Ill) were added to clean, suitably labelled tubes. A well-stirred suspension of solidphase antiserum (100 Ill) was then added to all tubes, which were allowed to stand for 30 minutes at room temperature. After addition of the enzyme label (loo Ill), the tubes were incubated overnight at 4°C. Substrate buffer containing detergent (3 ml) was added, and the tubes were centrifuged for 10 minutes at 1300 g. The supernatant was discarded, and the pellet was rewashed with detergent/buffer (3 ml) and, finally, with substrate buffer. The enzyme activity associated with the pellet was then determined by the standard procedure. The dose-response curve was plotted and the plasma cortisol concentration was calculated usingthe four-parameter model of Rodbard and Hutt (1974) .
REFERENCE GAS CHROMATOGRAPHY/ MASS SPECTROMETRY PROCEDURE
In brief, plasma samples were incubated with a [9, II, 12, 12-2 H41 cortisol internal standard and extracted. The extract was converted to the 3, 20-bismethyloxime, 11, 17, 21-tris-trimethylsilyl (TMS) ether, and cortisol and [2Hal cortisol were quantified by reference to a cortisol 3, 20-bis-ethyloxime, 11, 17, 21-tris-TMS ether chromatography standard. The procedure is described more fully elsewhere (Riad-Fahmy et al., 1979) .
Results and discussion
While enzymeimmunoassays possess certain intrinsic advantages, including the stability of the label and the cheapness of the equipment required, certain aspects of such assays must be optimised if they are to compete successfully with radioimmunoassay (RIA). Since an EIA for progesterone (Joyce et al., 1977) has been in routine use in our laboratory for over 18 months, with no technical difficulties and major savings in running costs arising from the elimination of scintillation fluid and vials, it was thought desirable to establish such an assay for plasma cortisol.
The use of solid-phase, coupled first antibody is associated with an essentially time-and temperatureindependent separation of free and bound steroid, which is technically simple, even for inexperienced staff (Riad-Fahmy et al., 1979) . The measurement of enzyme activity in the bound phase allows relaxation of purity criteria for the enzyme label, thus eliminating a time-consuming, difficult affinity chroma- plicate assays (n = 10) established that the assay had adequate precision over the range 0-50~gjdl. This dose-response curve covers the normal range of early morning samples, in both normal subjects and women taking contraceptive steroid preparations containing oestrogens. The precision between 50 and 100 llgjdl is adequate to evaluate Synacthen stimulation tests while the sensitivity (16,6 nmol/I) is adequate, by the sensitivity criterion of Kaiser and Specker (1956) , to monitor Addisonian subjects and dexamethasone suppression tests. Thus the assay will permit precise determination of the great majority of samples submitted at a single dilution. tography step and facilitating a simple wash procedure to minimise misclassification error (Wide, 1969) . Antisera were titrated against 3H-cortisol before and after coupling to activated cellulose to check that loss of activity in the coupling procedure was minimal.
While Rajkowski et at. (1977) have reported that the immobilised antiserum retained only 17 % of the original binding capacity, in our experience, recoveries of 60 % are routinely observed. The dilution of solid-phase antiserum (ljl000) corresponding to 50% binding of the radioligand was estimated from the dilution curve and used in the ElA.
The optimum mass of enzyme label was assessed by preparing trial standard curves using various masses of horseradish peroxidase-cortisol conjugate. A plot of optical density vs cortisol concentrations for various enzyme label concentrations is shown (Fig. 2) . A concentration of 70 ng/assay tube appeared to give best displacement and was chosen for further study.
The dose-response curve, prepared using the previously selected concentration of antiserum and A direct E1A for cortisol was obviously highly desirable, but the use of low pH to deactivate cortisol-binding globulin (979) was not possible since the low titre of the anti-cortisol-21-BSA serum available made the further decrease in titre, associated with reduced pH, unacceptable. Heat denaturation at neutral pH was found irreversibly to denature binding globulins, rendering them incapable of competing for cortisol. Cortisol standards were prepared in 'cortisol-free' plasma and heat-treated (FfI) or prepared in assay buffer without heat treatment, then processed in the assay (FB). The excellent agreement in data (r = 0'996; FH = 0·934 Fij + 0'286) allows the conclusion that cortisol has adequate stability when treated at 60°C for 30 minutes. Comparison of plasma concentrations determined directly, and after ethanol extraction, gave a correlation of 0·965 with a regression line F direct = 0·968 F extraction + 0'73~g/dl label. However, Ruder et al. (1972) , using a cortisol 21-antiserum with similar specificity to that reported here, did not observe any significant differences when they compared simple plasma extracts with those purified by a thin-layer chromatography procedure.
Plasma samples were, therefore, assayed by the present E1A procedure and by a previously reported reference GC-MS procedure (Riad-Fahmy et al., 1979) . Since the reference procedure combines two independent methods, both having high intrinsic specificity, the excellent correlation shown in Fig. 4 IiO
showing that cortisol may be determined accurately without extraction.
Cross reactions, based on the criteria of Abraham (1969) , are shown in Table 1 . The antiserum, raised to a cortisol, 2 [-BSA antigen, is relatively nonspecific, and the high cross-reactions of 17-hydroxyprogesterone and 11-and 2I-deoxycorlisol would5 have to be considered if an II or 2I-hydroxylase deficiency were suspected. Corticosterone concentrations are 10 %of those of cortisol, even in subjects receiving ACTH (Brown and Strott, 1971) , and this steroid is not likely to interfere significantly. While the specificity of antisera raised to cortisol-3 conjugated antigens is superior in assays employing 3H and 125I-radioligands (Fahmy et al., 1975; , it has not been possible to establish an EIA using such antisera with the homologous enzyme is good evidence for the accuracy of the enzyme assay. Further evidence is provided by comparison of assay results with those of a direct RIA, using a specific cortisol-3 antiserum and an lZ5I-radioligand, which has been in routine use in our laboratory for over 18 months. The correlation coefficient was r = 0'953, n = 20, with a regression line FEIA = 0'845 FRIA + 2·15 (~g/dl). While the slope of the line (0'845) is less satisfactory than the correlation, the difference between the two assays will not be clinically significant (FRIA = 6, FEIA = 7'2; FRIA = 20, FEIA = 19'1).
Since there is a diurnal rhythm in the secretion of many steroids, and also episodic secretion, the clinical value of suppression and stimulation tests has been increasingly recognised. Data obtained by the present assay in a short-term dexamethasone suppression test and Synacthen stimulation test are We thank Professor K. Griffiths for helpful advice and criticism and the Tenovus Organisation for financial support. We also thank the Government of Iraq for the provision of a training grant to RH.
Thus an EIA for cortisol is reported using an enzyme of well-proven stability which is commercially available with a suitably high specific activity. The use of a heat denaturation sample preparation, and a solid-phase technique for separating free and bound steroid, make this a simple robust procedure which has been shown to satisfy normal criteria of specificity and accuracy. The simplicity of the assay, with the stability of the label, should make this procedure especially suitable for the laboratory with a small or fluctuating workload. Fig. 5 Dexamethasone suppression test monitored by direct enzymeimmunoassay, Three normal subjects received oral dexamethasone tablets (1'0 and 0·5 mg) as indicated.
shown in Figures 5 and 6 . In each case, the response is within normal limits, confirming the utility of the assay in such dynamic tests.
